Risk of Developing Alzheimer Disease in Relation to Common Infections

Alejandra Camacho-Soto1, Irene Faust2, Osvaldo J Laurido-Soto3

  • 1Department of Physical Medicine and Rehabilitation, The University of Kansas Medical Center, Kansas City, Kansas, USA, acamacho-soto@kumc.edu.

PubMed
Abstract

Insights

Severe infections like meningitis and urinary tract infections (UTIs) may increase Alzheimer disease (AD) risk. Pneumonia showed no association with AD in this large US Medicare study.

Area of Science:

  • Neuroscience
  • Epidemiology
  • Infectious Diseases

Background:

  • Growing evidence links infections to Alzheimer disease (AD) pathogenesis, potentially via inflammation.
  • Previous studies on meningitis and AD risk were limited in scope and population.
  • This study investigates the association between AD and common infections in a large US population.

Purpose of the Study:

  • To examine the relationship between incident Alzheimer disease (AD) and three infections: meningitis, pneumonia, and urinary tract infections (UTIs).
  • To assess the impact of infection severity (hospitalization, sepsis) on the AD association.
  • To utilize a population-based sample of US Medicare beneficiaries for robust analysis.

Main Methods:

  • A case-control study design was employed, matching 52,628 AD cases with 210,512 controls from Medicare claims (2016-2018).
  • Infections were identified using ICD diagnosis codes, with analyses considering lagged exposures up to 18 months.
  • Logistic regression models calculated adjusted odds ratios (ORs) for associations, controlling for covariates and examining infection severity.

Main Results:

  • Meningitis hospitalization without sepsis showed a significant positive association with AD (OR=2.713) with a 6-month lag.
  • Urinary tract infections (UTIs) were positively associated with AD, both with (OR=1.388) and without sepsis (OR=1.231), with an 18-month lag.
  • No association was found between pneumonia and AD; outpatient UTIs showed an attenuated positive association, while outpatient pneumonia showed an inverse association.

Conclusions:

  • More severe infections, particularly meningitis, may be linked to an increased risk of Alzheimer disease (AD).
  • These findings suggest infections could either unmask prodromal AD or accelerate disease progression in susceptible individuals.
  • The study highlights the potential role of specific infections in AD etiology within a large, real-world healthcare dataset.

Related Concept Videos

Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
68
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.3K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
686
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
182
Role of Neurotransmitters in Memory01:23

Role of Neurotransmitters in Memory

Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
 Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
1.0K